Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers von Dooley, K E, Bliven-Sizemore, E E, Weiner, M, Lu, Y, Nuermberger, E L, Hubbard, W C, Fuchs, E J, Melia, M T, Burman, W J, Dorman, S E

Volltext

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials von Savic, RM, Weiner, M, MacKenzie, WR, Engle, M, Whitworth, WC, Johnson, JL, Nsubuga, P, Nahid, P, Nguyen, NV, Peloquin, CA, Dooley, KE, Dorman, SE

Volltext

Some comments on the Arcan mixed-mode (I/II) test specimen von Greer, J.M., Galyon Dorman, S.E., Hammond, M.J.

Volltext

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection von Dorman, S E, Holland, S M

Volltext

QuantiFERON®-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact von KASAMBIRA, T. S, SHAH, M, ADRIAN, P. V, HOLSHOUSER, M, MADHI, S. A, CHAISSON, R. E, MARTINSON, N. A, DORMAN, S. E

Volltext

Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil von Guerra, R. L., Dorman, S. E., Luiz, R. R., Conde, M. B.

Volltext

Viral infections in interferon-γ receptor deficiency von Dorman, Susan E., Uzel, Gulbu, Roesler, Joachim, Bradley, John S., Bastian, John, Billman, Glenn, King, Susan, Filie, Armando, Schermerhorn, James, Holland, Steven M.

Volltext

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection von Lammas, David, Dorman, Susan E, Altare, Frédéric, Edgar, David, Novelli, Vas, Heyne, Klaus, Holland, Steven M, Casanova, Jean-Laurent, Fondanèche, Marie-Claude, Dupuis, Stéphanie, Clarke, Jane, Lamhamedi-Cherradi, Salma, Fischer, Alain, Kumararatne, Dinakantha S, Ducoulombier, Henri, Emile, Jean-François, Schreiber, Robert D, Girdlestone, John, Jouanguy, Emmanuelle, Döffinger, Rainer, Oxelius, Vivi-Anne, Brai, Melchiorre

Volltext

Facilitators and barriers to adolescent participation in a TB clinical trial von Mangan, J.M., Hedges, K.N.C., Salerno, M.M., Tatum, K., Bouwkamp, B., Frick, M.W., McKenna, L., Muzanyi, G., Engle, M., Coetzee, J., Yvetot, J., Elskamp, M., Lamunu, D., Tizora, M.E. Theunissen, Namutamba, D., Chaisson, R.E., Swindells, S., Nahid, P., Dorman, S.E., Kurbatova, E.

Volltext

Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury von Szklo, A, Mello, F C Q, Guerra, R L, Dorman, S E, Muzy-de-Souza, G R, Conde, M B

Volltext

Abnormal Regulation of Interferon-γ, Interleukin-12, and Tumor Necrosis Factor-α in Human Interferon-γ Receptor 1 Deficiency von Holland, Steven M., Dorman, Susan E., Kwon, Annette, Pitha-Rowe, Ian F., Frucht, David M., Gerstberger, Susan M., Noel, Gary J., Vesterhus, Per, Brown, Margaret R., Fleisher, Thomas A.

Volltext

Fulminant babesiosis treated with clindamycin, quinine,and whole-blood exchange transfusion von Dorman, S.E., Cannon, M.E., Telford III, S.R., Frank, K.M., Churchill, W.H.

Volltext

Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis von Dawson, R., Narunsky, K., Carman, D., Gupte, N., Whitelaw, A., Efron, A., Barnes, G. L., Hoffman, J., Chaisson, R. E., McIlleron, H., Dorman, S. E.

Volltext

561del4 Defines a Novel Small Deletion Hotspot in the Interferon-γ Receptor 1 Chain von Rosenzweig, S., Dorman, S.E., Roesler, J., Palacios, J., Zelazko, M., Holland, S.M.

Volltext

Detection of Intracellular Phosphorylated STAT-1 by Flow Cytometry von Fleisher, Thomas A., Dorman, Susan E., Anderson, Jill A., Vail, Michael, Brown, Margaret R., Holland, Steven M.

Volltext

Interferon-γ and interleukin-12 pathway defects and human disease von Dorman, Susan E, Holland, Steven M

Volltext

Burkholderia pseudomallei Infection in a Puerto Rican Patient with Chronic Granulomatous Disease: Case Report and Review of Occurrences in the Americas von Dorman, Susan E., Gill, Vee J., Gallin, John I., Holland, Steven M.

Volltext

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis von Dorman, Susan E, Nahid, Payam, Kurbatova, Ekaterina V, Phillips, Patrick P.J, Bryant, Kia, Dooley, Kelly E, Engle, Melissa, Goldberg, Stefan V, Phan, Ha T.T, Hakim, James, Johnson, John L, Lourens, Madeleine, Martinson, Neil A, Muzanyi, Grace, Narunsky, Kim, Nerette, Sandy, Nguyen, Nhung V, Pham, Thuong H, Pierre, Samuel, Purfield, Anne E, Samaneka, Wadzanai, Savic, Radojka M, Sanne, Ian, Scott, Nigel A, Shenje, Justin, Sizemore, Erin, Vernon, Andrew, Waja, Ziyaad, Weiner, Marc, Swindells, Susan, Chaisson, Richard E

Volltext

Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis von Arias, Mayra, Mello, Fernanda C. Q., Pavón, Ada, Marsico, Anna Grazia, Alvarado-Gálvez, Carlos, Rosales, Senia, Pessôa, Carlos Leonardo Carvalho, Pérez, Melly, Andrade, Monica K., Kritski, Afranio L., Fonseca, Leila S., Chaisson, Richard E., Kimerling, Michael E., Dorman, Susan E.

Volltext

Fluoroquinolone Resistance in Patients with Newly Diagnosed Tuberculosis von Ginsburg, Amy Sarah, Hooper, Nancy, Parrish, Nikki, Dooley, Kelly E., Dorman, Susan E., Booth, Jay, Diener-West, Marie, Merz, William G., Bishai, William R., Sterling, Timothy R.

Volltext